Acasti Pharma
Company Review
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
- Biotechnology
- Laval, Canada
Primary Stock Exchange Listings
Ticker Symbol:
ACST
TSX Venture Exchange
Canada
